Sweden: Merck Sharp & Dohme v. Paranova, T 2694-14, District Court of Stockholm, 18 June 2015
May 13, 2016
In February 2014, Merck Sharp & Dohme Corp. (“MSD”) brought proceedings against Paranova Läkemedel AB (“Paranova”), alleging that Paranova was violating MSD’s right as an exclusive licensee of the European patent EP 0 595 935 ("EP 935") by taking preparatory measures for parallel importation. MSD applied for a permanent injunction and corrective measures as well as a preliminary injunction. The Stockholm District Court granted a permanent injunction and held that the approved application for authorization of parallel importation from the European Medicines Agency (EMA) was considered to constitute imminent infringement.
A full summary of this case has been published on Kluwer IP Law.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
